Menu Search
Equities

Paul Hartmann AG

PHH2:FRA

Paul Hartmann AG

Actions
Health CareMedical Equipment and Services
  • Price (EUR)196.50
  • Today's Change0.00 / 0.00%
  • Shares traded30.00
  • 1 Year change+8.86%
  • Beta0.3448
Data delayed at least 15 minutes, as of Nov 08 2024 07:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Paul Hartmann AG's net income fell -21.37% from 36.15m to 28.42m despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 43.33% to 43.99%.
Gross margin58.00%
Net profit margin2.70%
Operating margin4.46%
Return on assets3.19%
Return on equity5.34%
Return on investment4.19%
More ▼

Cash flow in EURView more

In 2023, Paul Hartmann AG increased its cash reserves by 34.60%, or 37.31m. The company earned 230.79m from its operations for a Cash Flow Margin of 9.81%. In addition the company used 113.48m on investing activities and also paid 77.32m in financing cash flows.
Cash flow per share47.38
Price/Cash flow per share4.17
Book value per share318.25
Tangible book value per share247.07
More ▼

Balance sheet in EURView more

Paul Hartmann AG has a Debt to Total Capital ratio of 20.82%, a lower figure than the previous year's 21.36%.
Current ratio2.30
Quick ratio1.31
Total debt/total equity0.2629
Total debt/total capital0.2082
More ▼

Growth rates in EUR

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -21.37%. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is below the industry average.
Div yield(5 year avg)2.81%
Div growth rate (5 year)2.71%
Payout ratio (TTM)47.71%
EPS growth(5 years)-18.49
EPS (TTM) vs
TTM 1 year ago		156.12
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.